Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12847]

ASCO GI: Pre-operative oral capecitabine chemotherapy is equivalent to infusional 5-FU for rectal cancer

ASCO GI: Pre-operative oral capecitabine chemotherapy is equivalent to infusional 5-FU for rectal cancer

ASCO GI: New, rationally-based chemotherapy combination appears highly effective in patients with treatment-resistant neuroendocrine tumours

ASCO GI: New, rationally-based chemotherapy combination appears highly effective in patients with treatment...

ASCO GI: Adding the targeted therapy ramucirumab to standard second-line chemotherapy improves survival, quality of life for patients with metastatic gastric cancer

ASCO GI: Adding the targeted therapy ramucirumab to standard second-line chemotherapy improves survival, quality...

Screening helps prevent cervical cancer in older women

Screening helps prevent cervical cancer in older women

Breast cancer patients experience fewer side effects from anticancer drug when receiving either real or sham acupuncture

Breast cancer patients experience fewer side effects from anticancer drug when receiving either real or sham...

Mechanism affecting risk of prostate cancer is found

Mechanism affecting risk of prostate cancer is found

Advanced radiation therapy for head and neck cancer may be better than traditional radiation at preventing side effects and cancer recurrence

Advanced radiation therapy for head and neck cancer may be better than traditional radiation at preventing side...

FDA approval for combination of trametinib with dabrafenib for treatment of melanoma

FDA approval for combination of trametinib with dabrafenib for treatment of melanoma

Immune checkpoint inhibitor shows early promise in previously treated lung cancer patients

Immune checkpoint inhibitor shows early promise in previously treated lung cancer patients

New discovery of biomarker to improve diagnosis, prognosis and treatment of oesophageal squamous cell carcinoma

New discovery of biomarker to improve diagnosis, prognosis and treatment of oesophageal squamous cell carcinoma

More from ecancer